enVVeno Medical (NASDAQ:NVNO) Cut to Sell at Wall Street Zen

Wall Street Zen cut shares of enVVeno Medical (NASDAQ:NVNO) from a hold rating to a sell rating in a report issued on Sunday morning,Wall Street Zen reports.

Other equities analysts have also recently issued reports about the stock. LADENBURG THALM/SH SH raised shares of enVVeno Medical from a “hold” rating to a “strong-buy” rating in a research note on Monday, July 6th. Weiss Ratings reaffirmed a “sell (e+)” rating on shares of enVVeno Medical in a research report on Friday, September 25th. Finally, Zacks Research raised shares of enVVeno Medical to a “hold” rating in a research report on Tuesday, July 7th. One research analyst has rated the stock with a Strong Buy rating, one has assigned a Hold rating and one has issued a Sell rating to the company’s stock. Based on data from MarketBeat, the stock currently has an average rating of “Hold”.

enVVeno Medical Stock Up 4.5%

NASDAQ:NVNO opened at $7.18 on Friday. The firm has a market capitalization of $4.95 million, a price-to-earnings ratio of -0.37 and a beta of 1.40. enVVeno Medical has a twelve month low of $6.52 and a twelve month high of $24.84. The stock’s 50 day moving average price is $8.83 and its two-hundred day moving average price is $10.27.

enVVeno Medical (NASDAQ:NVNO) last announced its quarterly earnings data on Thursday, October 29th. The company reported ($6.29) earnings per share (EPS) for the quarter, missing analysts’ consensus estimates of ($3.27) by ($3.02). As a group, analysts anticipate that enVVeno Medical will post -16.19 earnings per share for the current year.

About enVVeno Medical

enVVeno Medical Corporation (NASDAQ:NVNO) is a late-stage medical device company focused on developing bioprosthetic, or tissue-based, treatments for venous disease. Its primary focus is chronic venous insufficiency, a condition in which damaged or absent valves allow blood to flow backward in the veins and can cause swelling, pain, skin changes and ulcers.

The company’s lead product is the VenoValve, a surgically implanted bioprosthetic valve designed to restore one-way blood flow in the deep veins of the leg.